Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Entecavir for Reducing the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients With Compensated Cirrhosis and Low Viral Load: a Multicenter, Prospective Study

NCT04646928 is registered in ClinicalTrials.gov with CHA University as lead sponsor.

NCT NCT04646928
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04646928 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Entecavir for Reducing the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients With Compensated Cirrhosis and Low Viral Load: a Multicenter, Prospective Study
Lead sponsor
CHA University
Phase
Observational
Overall status
Unknown status
Start date
March 17, 2017
Completion date
August 26, 2022
Enrollment
245 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b